Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Mycobacterium Tuberculosis Market Be Worth By 2029?

In recent times, the market for mycobacterium tuberculosis has experienced steady growth. The figure is forecast to rise from $3.54 billion in 2024 to $3.73 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.2%. Predominant factors propelling growth in the past include an upsurge in TB incidences in highly burdened nations, enhanced financial support from global institutions, broadening of TB diagnostic programs, increasing cases of TB and HIV co-infections, and an increase in international movement and immigration, leading to the spread of TB.

A substantial growth is predicted for the mycobacterium tuberculosis market in the coming years, reaching $4.54 billion by 2029 at a CAGR of 5.0%. Factors contributing to this growth include the global increase in TB incidence, the spread of drug-resistant TB, a rising awareness of TB transmission and prevention, government-led initiatives and funding for TB eradication, and escalated R&D in TB treatment. The forecast period is expected to witness significant advancements in TB diagnosis technologies, rapid TB testing methods, introduction of new TB vaccines, development of pioneering drug therapies for multidrug-resistant TB, and technological progression in TB drug formulation.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24325&type=smp

Which Key Factors Are Fueling Growth In The Mycobacterium Tuberculosis Market?

The increase in funds directed towards research and development is projected to fuel progress and expansion in the mycobacterium tuberculosis market. Research and development denote the generation of novel knowledge or advancement of current products, services, or technologies through comprehensive investigation and trials. This process is on the rise due to quick technological developments, driving the demand for ongoing innovation to remain competitive in rapidly changing global markets. Such research and development efforts aid the treatment of mycobacterium tuberculosis by identifying new potential drugs capable of countering resistance to existing treatments, thus enhancing patient results and the efficacy of treatments. For example, in March 2024, as per a report by the Foreign, Commonwealth, and Development Office, a government department in the UK, the UK government declared a funding surge of $5 million (£4 million) for the TB REACH programme to back creative approaches for ameliorating detection and treatment of tuberculosis in low to middle-income nations. Through this assistance, half a million individuals will gain access to healthcare, 37,000 will get their TB detected, and potentially over 15,000 lives could be saved. Hence, the increase in investments towards research and development is set to stimulate the development of the mycobacterium tuberculosis market.

Which Segmentation Factors Are Critical In The Mycobacterium Tuberculosis Market Analysis?

The mycobacterium tuberculosismarket covered in this report is segmented –

1) By Product Type: Instruments; Reagents And Consumables; Software Solutions

2) By Diagnostic Method: Culture-Based Methods; Molecular Diagnosis; Immunological Tests

3) By Route Of Administration: Oral; Injectable

4) By End User: Hospitals; Diagnostic Laboratories; Research Institutions

Subsegments:

1) By Instruments: Diagnostic Instruments; Detection Instruments; Molecular Diagnostic Instruments; Tuberculosis Culture Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Reagents; Tuberculosis Culture Media; Antigen Kits; Test Strips; Tuberculosis Diagnostic Kits

3) By Software Solutions: Laboratory Information Management Systems (LIMS); Diagnostic Software; Data Management Software; Telemedicine Solutions for TB Diagnosis

How Are Global Trends Impacting The Development Of The Mycobacterium Tuberculosis Market?

Key players in the mycobacterium tuberculosis market are concentrating their efforts on creating innovative solutions such as automated tuberculosis tests. These tests utilize advanced technology and automated systems to quickly and accurately determine the presence of Mycobacterium tuberculosis and drug resistance, requiring minimal human interaction. For instance, in April 2025, U.S biotech firm Revvity Inc. received FDA approval for their Auto-Pure 2400 liquid handling platform, which integrates with the T-SPOT TB test. The combination of the two enhances automated tuberculosis testing by managing higher volume processing without sacrificing precision. This solution merges liquid handling with magnetic cell isolation technology, allowing testing of up to 24 samples per run and completing the first day of testing in less than 3.5 hours with minimal user involvement. Proclaimed by WHO as the only ELISPOT-based IGRA, the T-SPOT.TB test provides consistent results with fewer unclear results. This reduces the need for additional testing and offers dependable performance when working with immunocompromised patients.

Which Players Are Shaping The Competitive Landscape Of The Mycobacterium Tuberculosis Market?

Major companies operating in the mycobacterium tuberculosis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Macleods Pharmaceuticals Limited, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Lupin Limited, Zydus Cadila Healthcare Limited, Cepheid Inc., Serum Institute of India Pvt. Ltd., Oxford Immunotec USA Inc., Panacea Biotec Limited, International AIDS Vaccine Initiative Inc., HiMedia Laboratories Private Limited, Akonni Biosystems Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/mycobacterium-tuberculosis-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Mycobacterium Tuberculosis Market?

North America was the largest region in the mycobacterium tuberculosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mycobacterium tuberculosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24325&type=smp

Browse Through More Reports Similar to the Global Mycobacterium Tuberculosis Market 2025, By The Business Research Company

Tuberculosis Diagnostics Market 2025

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-market

Tuberculosis Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

Acute Bacterial Skin And Skin Structure Infections Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/acute-bacterial-skin-and-skin-structure-infections-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model